Business
BioSpectrum Asia
APAC building on enough supply network for radiopharmaceuticals
The radiopharmaceutical industry is gaining ground across the Asia-Pacific (APAC) region, as countries not only step up development of novel therapies but also move to secure critical supply chains. From new partnerships to domestic isotope production, let's explore how APAC is building a foothold in this specialised sector.
4 min |
BioSpectrum Asia August 2025
BioSpectrum Asia
Singapore-Korea partnership to apply Al in hair follicle regeneration research
Singapore-based startup NYB.AI and Pnaseer Inc., a startup based in South Korea, have announced a strategic partnership to accelerate the discovery of compounds that promote hair follicle regeneration using artificial intelligence (AI).
1 min |
BioSpectrum Asia August 2025
BioSpectrum Asia
Sartorius expands manufacturing and R&D capacities for innovative bioprocess solutions in France
The life science group Sartorius recently celebrated the completion of a multi-year capacity expansion project at the headquarters of its French sub-group Sartorius Stedim Biotech in Aubagne.
1 min |
BioSpectrum Asia July 2025
BioSpectrum Asia
PCI Growth in Malaysia: Innovations Transforming Cardiovascular Care
The number of PCI procedures with stents has risen dramatically in Malaysia in recent years and is set to see further significant growth, driven by rising CVD prevalence, demographic shifts, and technological advancements. Since the introduction of DES, there has not been a successful major technological advance in stent technology for over two decades. However, results from the INFINITY-SWEDEHEART Trial, published in The Lancet in November 2024 indicate that a novel technology is set to challenge the dominance of DES in the PCI market.
4 min |
BioSpectrum Asia July 2025
BioSpectrum Asia
IonOpticks Generation 4 Aurora Series sets new benchmark in chromatography
Australia-based IonOpticks, developer of chromatography columns for mass spectrometry research, has announced the launch of its 4th Generation of Aurora Series columns.
1 min |
BioSpectrum Asia July 2025
BioSpectrum Asia
ThinkCyte unveils cloud-based platform for AI-driven cell morphology data analysis
ThinkCyte, a Japan-based life science company pioneering advanced artificial intelligence (AI)-powered cell analysis and sorting technologies, has announced the precommercial launch of MorphoScan Cloud, its new cloud-based platform designed for flexible data access, faster processing, and advanced AI– driven analysis.
1 min |
BioSpectrum Asia July 2025
BioSpectrum Asia
Japan's strategic medtech alignment with India
Given Japan's ageing population and the increasing number of patients with chronic and lifestyle diseases, Japan's market for medical devices continues to be among the world's largest.
6 min |
BioSpectrum Asia July 2025
BioSpectrum Asia
Quadria Group takes control of HealthQuad for launching Fund III with corpus of $300 M
Quadria Group, Asia's leading healthcare-focused private equity platform, has announced the launch of HealthQuad Fund III, with a proposed raise of up to $300 million (target corpus of $200 million with a $100 million greenshoe option).
1 min |
BioSpectrum Asia July 2025
BioSpectrum Asia
ClavystBio and A*STAR partner to grow medtech ventures in Singapore
ClavystBio, a life sciences investor and venture builder established by Temasek, and the Agency for Science, Technology and Research (A*STAR), Singapore's lead public sector R&D agency, have signed a Memorandum of Understanding (MOU) to create and grow medtech ventures in Singapore.
1 min |
BioSpectrum Asia July 2025
BioSpectrum Asia
Japan transforms engineered heart tissues for precise drug testing
A research team at Kyoto University in Japan has developed a novel engineered heart tissue (EHT) platform using low-absorption polystyrene (PS) that overcomes the limitations of current devices, enabling rigorous in vitro evaluation of drug responses and streamlining preclinical testing by minimising the need for conventional animal experiments.
1 min |
BioSpectrum Asia July 2025
BioSpectrum Asia
Olympus announces full market release of AI-powered emphysema screening programme
Japan headquartered medtech firm Olympus Corp. has announced the full market release of its artificial intelligence (AI)-driven emphysema screening programme, SeleCT Screening.
1 min |
BioSpectrum Asia July 2025
BioSpectrum Asia
Hong Kong leads global drug development using new dual immunotherapy
A research team from the School of Clinical Medicine of the LKS Faculty of Medicine of the University of Hong Kong (HKUMed) has pioneered the use of a 'dual immunotherapy' combinationnivolumab and ipilimumab (NIVO+IPI), in the treatment of liver cancer patients.
1 min |
BioSpectrum Asia July 2025
BioSpectrum Asia
Joint action plans to tackle viral hepatitis in Africa
Considering the general decline in funding for research and development, Africa Centres for Disease Control and Prevention (Africa CDC), in collaboration with the World Hepatitis Alliance (WHA) and the African Viral Hepatitis Action Group (AVHAG), has developed a capacity-building programme for hepatitis elimination and advocacy.
1 min |
BioSpectrum Asia July 2025
BioSpectrum Asia
AusBiotech & Austrade ink partnership to accelerate.global expansion of life sciences industry
Aus Biotech, Australia's peak body for the life sciences sector, and the Australian Government's Trade and Investment Commission (Austrade) are partnering to accelerate the global growth and expansion of Australian life science companies.
1 min |
BioSpectrum Asia July 2025
BioSpectrum Asia
UltraGreen.ai acquires Perfusion Tech
UltraGreen.ai, a Singapore-headquartered leader in surgical imaging technology, has announced the acquisition of Perfusion Tech, a clinical software innovator focused on real-time perfusion quantification during surgical procedures.
1 min |
BioSpectrum Asia July 2025
BioSpectrum Asia
AriBio licenses Alzheimer's drug to Arcera in $600 M deal
AriBio Co., a South Korean biopharmaceutical company specialising in neurodegenerative diseases, and a Swiss pharmaceutical company Acino, part of Arcera, a global life sciences company based in Abu Dhabi, have announced the signing of exclusive licensing and commercialisation, and supply agreements for AR1001, an investigational oral therapy for Alzheimer’s disease.
1 min |
BioSpectrum Asia July 2025
BioSpectrum Asia
HekaBio teams up with Alfresa Holdings accelerating access to innovative therapies in Japan
HekaBio K.K. has announced the signing of a strategic partnership agreement with Alfresa Holdings Corporation, a leading pharmaceutical wholesaler group in Japan. As part of this agreement, Alfresa Holdings has also made a capital investment in HekaBio.
1 min |
BioSpectrum Asia July 2025
BioSpectrum Asia
Medison expands global leadership team
Israel-based Medison, the creator of a first-of-its-kind unified global commercialisation platform that accelerates the launch of breakthrough therapies in markets beyond the US, Western Europe, and Japan, has announced two key additions to its global leadership team: c. Shay Tamari, newly appointed Chief Business Officer, will lead Medison's global corporate development strategy.
1 min |
BioSpectrum Asia July 2025
BioSpectrum Asia
Global leaders unite to accelerate cervical cancer elimination efforts
Governments, donors, multilateral institutions, the private sector and partners have announced significant policy, programmatic and financial commitments to eliminate one of the most preventable cancers.
1 min |
BioSpectrum Asia July 2025
BioSpectrum Asia
Indonesia and Thailand ink health MoU focusing on global capacity and collaboration
In a series of official visits by the President of the Republic of Indonesia Prabowo Subianto to Thailand, bilateral cooperation between the two countries was strengthened through the signing of a Memorandum of Understanding (MOU) in the health sector.
1 min |
BioSpectrum Asia July 2025
BioSpectrum Asia
Medical Advances Soar With APAC’S CLINICAL TRIAL GROWTH
It's universally acknowledged that Asia-Pacific (APAC) is a hotbed for clinical trials, with multiple reports confirming that it is the only region in the world to have seen a consistent surge in clinical trial activity.
10+ min |
BioSpectrum Asia July 2025
BioSpectrum Asia
AstraZeneca inks collaboration worth $3.6 B with CSPC Pharma in China
AstraZeneca has entered a strategic research collaboration with Shijiazhuang City-based CSPC Pharmaceuticals Group.
1 min |
BioSpectrum Asia July 2025
BioSpectrum Asia
"By removing structural dependence, we unlock the full potential of AI for drug discovery"
Gero, a Singapore-based biotech company focused on aging and chronic diseases, launched ProtoBind-Diff, an AI model that generates small molecules for specific protein targets—using only the amino acid sequence, without needing 3D structural data.
5 min |
BioSpectrum Asia July 2025
BioSpectrum Asia
MarkHerz signs MoU with German university hospital for research on next-generation gene therapies
MarkHerz Inc., a South Korea-based biotechnology startup specialising in AAV-based gene therapies targeting cardiovascular and metabolic diseases, has signed a Memorandum of Understanding (MoU) with Klinikum rechts der Isar, the university hospital affiliated with the Technical University of Munich (TUM), Germany.
1 min |
BioSpectrum Asia July 2025
BioSpectrum Asia
WHO issues first global guideline to improve pregnancy care for women with sickle cell disease
The World Health Organization (WHO) has released its firstever global guideline on the management of sickle cell disease (SCD) during pregnancy, addressing a critical and growing health challenge that can have life-threatening consequences for both women and babies. Health risks associated with SCD intensify during pregnancy, due to heightened demands on the body's oxygen and nutrient supply.
1 min |
BioSpectrum Asia July 2025
BioSpectrum Asia
Sun Pharma names Kirti Ganorkar as new Managing Director
Sun Pharmaceutical Industries, based in India, has announced the appointment of Kirti Ganorkar as the Managing Director (MD) to succeed Dilip Shanghvi, effective September 1, 2025, with the entire business and all functions reporting to him.
1 min |
BioSpectrum Asia July 2025
BioSpectrum Asia
Waters enhances Alliance iS HPLC System software
Waters Corporation has announced the release of version 2.0 of the Alliance iS HPLC System software, a significant advancement that provides full end-to-end traceability and enhanced data security for the pharmaceutical industry.
1 min |
BioSpectrum Asia July 2025
BioSpectrum Asia
Vietnam Vaccine JSC injects $77 M in new manufacturing unit
Vietnam Vaccine Joint Stock Company (VNVC) has begun construction on its 26,000 square meter factory building with an investment of VND2 trillion ($77.17 million).
1 min |
BioSpectrum Asia July 2025
BioSpectrum Asia
HekaBio teams up with Alfresa Holdings accelerating access to innovative therapies in Japan
HekaBio K.K. has announced the signing of a strategic partnership agreement with Alfresa Holdings Corporation, a leading pharmaceutical wholesaler group in Japan.
1 min |
BioSpectrum Asia July 2025
BioSpectrum Asia
Eastern Caribbean launches project to strengthen pandemic preparedness
A landmark initiative to boost pandemic preparedness and response in the Eastern Caribbean has been launched in Castries, Saint Lucia, bringing renewed focus to building resilient, integrated health systems that can better detect and respond to future health threats.
1 min |